Independent public-source research Read our evidence standard
ChinaSteals Search
Menu
← All case files CS-010 / Last reviewed Aug 23, 2026 Jump to sources ↓

Life sciences & research / 2007–2026

Two hospital researchers commercialized stolen exosome trade secrets in China

A married research team used long-term laboratory access to take exosome-isolation methods, establish a company in China, seek government support, and sell products and services built from the hospital’s work.

Finding

Yu Zhou and Li Chen pleaded guilty to conspiring to steal trade secrets and commit wire fraud. They received prison sentences and joint restitution exceeding $2.6 million; a federal court revoked their naturalizations in 2026.

01 / Executive brief

Executive summary

Yu Zhou and Li Chen spent roughly a decade each inside research programs at Nationwide Children's Hospital. Their trusted positions exposed them to methods for isolating exosomes—tiny biological packages with potential diagnostic and therapeutic value—including a protected technique that worked from a single drop of blood. S1S2S3S4

While still connected to the hospital, the married researchers created and operated a company in China without the institution's knowledge, used at least five stolen trade secrets in its business, advertised related products and services, and pursued government-linked funding and benefits. Both pleaded guilty, received prison terms and joint restitution exceeding $2.6 million, and later had their U.S. naturalizations revoked in federal civil proceedings. S1S2S3S4S5

Side-by-side identification photographs of Yu Zhou and Li Chen
portrait

Yu Zhou, left, and Li Chen, the married researchers who pleaded guilty to conspiring to steal exosome-related trade secrets from Nationwide Children's Hospital. DCSA/CDSE publishes these identification photographs with its official case study.

Defense Counterintelligence and Security Agency / CDSE · Editorial use; published by DCSA/CDSE
Scientific diagram showing how extracellular vesicles called exosomes form and leave a cell
illustration

Exosomes are nanoscale extracellular vesicles with diagnostic and therapeutic potential. The stolen methods concerned isolating them, including from a single drop of blood. Contextual scientific illustration.

Law ZJ, Khoo XH, Lim PT, Goh BH, Ming LC, Lee WL, and Goh HP · CC BY 4.0 ↗

02 / The vignette

What happened

Long tenure created deep laboratory access

Zhou worked at the institute from 2007 to 2017 and Chen from 2008 to 2018. Years inside the same research environment gave them more than access to documents: they learned the experimental sequence, materials, troubleshooting, and practical know-how behind exosome isolation. Their pleas covered at least five trade secrets, including the one-drop-of-blood method. S1S2

A hidden company commercialized the work

The pair formed and operated a company in China without Nationwide Children's knowledge. Court records describe the company advertising products and services derived from hospital methods and entering a substantial commercialization agreement. The record also documents government-linked funding or benefits, though it does not prove that a PRC agency ordered or managed the theft. S1S2S3S5

Criminal pleas were followed by civil consequences

Chen pleaded guilty in July 2020 and Zhou that December. They received 30- and 33-month prison terms, forfeiture orders, and joint restitution of $2,616,087. In March 2026, a federal judge entered civil orders revoking both naturalizations; because those orders were recent at review, later appellate activity remains an update point. S2S3S4S5

03 / Anatomy

How access became transfer

This chain reconstructs the sequence supported by the cited record. It does not imply that every legitimate relationship follows the same path.

  1. 01

    Relationship established

    Long-term researchers

    Zhou and Chen each worked for roughly a decade in research roles at Nationwide Children’s Hospital. S1S3S4

  2. 02

    Sensitive access gained

    Laboratory know-how

    Their roles gave them access to methods for isolating exosomes and related hospital research materials. S1S2

  3. 03

    Information acquired

    Trade secrets taken

    Their guilty pleas admitted a conspiracy to steal at least five trade secrets, including a method for isolating exosomes from a single drop of blood. S1S2

  4. 04

    Assets moved

    Company formed in China

    They established and operated a company in China without the hospital’s knowledge and used its communications and commercial activity to move the work outside the institution. S1S2

  5. 05

    Technology put to use

    Commercialized abroad

    The company advertised products and services derived from the stolen exosome-isolation technology and entered a substantial commercialization agreement. S2S3

  6. 06

    Competitive harm

    Criminal and civil judgments

    Both defendants received prison and restitution sentences; in 2026 a federal judge also revoked their U.S. naturalizations. S3S4S5

04 / Evidence boundary

What is established—and what is not

Established in the record

  • Both researchers admitted the charged conspiracy through guilty pleas; the central misconduct is adjudicated rather than merely alleged. S1S2
  • The stolen assets included at least five trade secrets concerning exosome isolation, including a method using one drop of blood. S1S2
  • They operated a company in China without the hospital’s knowledge and pursued commercial value from the hospital-derived methods. S1S2S3
  • The record documents Chinese government-linked funding or benefits, but does not establish state direction of the theft. S1S5

Uncertain, limited, or unresolved

  • Public records document funding and benefits associated with Chinese government programs, but do not prove that a PRC agency ordered or managed the underlying theft. S1S5
  • Because the 2026 denaturalization orders were recent when this file was reviewed, later civil appellate activity may require an update. S5

Subject response / procedural context

  • Zhou and Chen each pleaded guilty and admitted the conspiracy conduct described in their criminal cases; this review found no separate public denial that alters those admissions. S1S2

05 / Sequence

Timeline

  1. Research access

    Zhou worked at the institute from 2007 to 2017 and Chen from 2008 to 2018. S1

  2. Chen pleads guilty

    Chen admitted conspiring to steal trade secrets and commit wire fraud, including conduct involving at least five hospital trade secrets. S2

  3. Zhou pleads guilty

    Zhou pleaded guilty to the same conspiracy offenses and admitted his role in the scheme. S1

  4. Chen sentenced

    The court sentenced Chen to 30 months in prison and ordered restitution and forfeiture. S3

  5. Zhou sentenced

    The court sentenced Zhou to 33 months in prison, imposed a fine, and ordered joint restitution and forfeiture. S4

  6. Naturalizations revoked

    A federal judge entered civil orders revoking both defendants’ naturalizations after finding they had been illegally procured. S5

06 / People and institutions

Who appears in the public record

Yu Zhou

Former Nationwide Children’s Hospital researcher and co-founder of a company in China

Outcome: Pleaded guilty; sentenced to 33 months, a fine, restitution, and forfeiture; naturalization revoked in 2026

Li Chen

Former Nationwide Children’s Hospital researcher and co-founder of a company in China

Outcome: Pleaded guilty; sentenced to 30 months, restitution, and forfeiture; naturalization revoked in 2026

Originator / affected institution

Nationwide Children’s Hospital Research Institute

Employer and owner of the exosome-related trade secrets developed in its laboratories

07 / Consequences

Documented and attributed harm

Court finding

The sentencing court imposed joint restitution of $2,616,087, reflecting the loss amount used in the criminal judgments. S3S4

Documented record

Chen admitted that, after the one-drop isolation method was taken, the hospital could no longer perform that isolation method in its laboratory. S2

Documented record

The couple received nearly $1.5 million in transactions tied to the scheme, according to the 2026 Justice Department summary of the court record. S5

08 / Hindsight analysis

Where leadership could have seen risk

These are our analytic judgments based on the public record, not court findings. They are framed to improve controls without treating nationality as a risk factor.

Outside interests were invisible

The researchers operated a related company abroad without the hospital’s knowledge. Conflict disclosures were not connected tightly enough to technical access and commercialization monitoring.

Know-how could leave without a file

Laboratory methods include tacit steps, sample handling, and troubleshooting knowledge. Controls focused only on documents would miss much of what made the method reproducible.

Long tenure reduced scrutiny

A decade of trusted work created sustained access. Mature insider-risk programs reevaluate changing outside ties and access patterns without treating longevity as a substitute for controls.

09 / Apply the lesson

Actions leaders can take

  1. universities

    Join disclosures to access review

    Reconcile outside appointments, equity, companies, patents, talent-program participation, and foreign funding with laboratory access and sponsored-research obligations at least annually.

  2. both

    Map tacit knowledge

    Identify the protocols, samples, settings, supplier knowledge, and troubleshooting steps that make high-value research reproducible; protect them as a system, not only as files.

  3. universities

    Set commercialization tripwires

    Monitor lawful public signals—new companies, patents, product claims, websites, and licensing activity—for overlap with protected institutional work, with counsel-defined review thresholds.

  4. both

    Preserve a safe reporting channel

    Give colleagues a confidential route to report undeclared companies, unusual sample movements, or pressure to bypass material-transfer and licensing processes.

10 / Source record

Sources

Links point to the public record reviewed for this file. Government releases can summarize court proceedings but remain government-authored sources; the source note identifies those limits.

  1. S1

    Man Who Worked at Local Research Institute for 10 Years Pleads Guilty to Conspiring to Steal Trade Secrets ↗

    U.S. Department of Justice · Published Dec 11, 2020 · Retrieved Aug 23, 2026

    Zhou plea summary with employment, company, technology, and government-benefit facts.

    government release
  2. S2

    Plea Agreement: United States v. Li Chen ↗

    U.S. District Court for the Southern District of Ohio via U.S. Department of Justice · Published Jul 30, 2020 · Retrieved Aug 23, 2026

    Signed plea agreement and statement of facts.

    court record
  3. S3

    Hospital Researcher Sentenced to Prison for Conspiring to Steal Trade Secrets and Sell Them in China ↗

    U.S. Department of Justice · Published Feb 1, 2021 · Retrieved Aug 23, 2026

    Chen sentencing summary, including restitution and forfeiture.

    government release
  4. S4

    Hospital Researcher Sentenced to Prison for Conspiring to Steal Trade Secrets and Sell Them in China ↗

    U.S. Department of Justice · Published Apr 20, 2021 · Retrieved Aug 23, 2026

    Zhou sentencing summary, including the fine, joint restitution, and forfeiture.

    government release
  5. S5

    Federal Judge Revokes Naturalization of Married Couple Who Conspired to Steal Medical Trade Secrets and Share Them with China ↗

    U.S. Department of Justice · Published Mar 31, 2026 · Retrieved Aug 23, 2026

    Summary of March 30, 2026 civil orders and the underlying criminal record.

    government release